NCT07035301View on ClinicalTrials.gov

Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures

NARecruitingINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

January 31, 2028

Conditions
Disease of Respiratory System
Interventions
DRUG

Normal Saline (Placebo)

During anesthesia induction, an equal volume of normal saline was used instead of rocuronium for anesthesia.

DRUG

Lidocaine Intravenous Infusion

Lidocaine was administered at a dose of 0.5mg/kg for the induction of anesthesia.

DRUG

Remimazolam Tosilate

Remimazolam was administered at a dose of 0.2 mg/kg for the induction of anesthesia.

DRUG

Remifentanil

Remifentanil was administered at a dose of 3 micrograms per kilogram for the induction of anesthesia.

DRUG

Rocuronium (0.15mg/kg/body mass)

Rocuronium was administered at a dose of 0.15mg/kg for the induction of anesthesia.

Trial Locations (1)

150001

RECRUITING

The First Affiliated Hospital of Harbin Medical University, Harbin

All Listed Sponsors
collaborator

First Affiliated Hospital of Harbin Medical University

OTHER

lead

Harbin Medical University

OTHER